INT867
From wiki-pain
|
|
|
|
|
Sentences Mentioned In
Key: | Protein | Mutation | Event | Anatomy | Negation | Speculation | Pain term | Disease term |
Serum IFN was undetectable after single doses of 1 x 10(6) to 18 x 10(6) IU, but 60 x 10(6) IU resulted in measurable levels of circulating IFN in 3 out of 6 patients. | |||||||||||||||
| |||||||||||||||
|
The interferon was produced in leukocyte cultures and was given intramuscularly in one daily dose of 1 million units for 5-8 days. | |||||||||||||||
| |||||||||||||||
|
In the interferon-treated patients interferon was detectable in serum (peak level 1-5 hours after interferon injections) and in vesicle fluid, and in some patients also in urine samples. | |||||||||||||||
| |||||||||||||||
|
In vitro exposure of rodent and human lymphocytes to cannabinoids depresses their transformation, natural killer activity, and interferon production. | |||||||||||||||
| |||||||||||||||
|
From Trypanosoma brucei brucei, a molecule has been isolated which triggers the production of IFN-gamma by CD8+ T-cells. | |||||||||||||||
| |||||||||||||||
|
Levels of IL-18 in the supernatants, and levels of IL-18, IL-12, interferon (IFN)-gamma and soluble CD14 in the serum were analysed by ELISA technique. | |||||||||||||||
| |||||||||||||||
|
Via interaction with Toll-like receptor 7 on immune cells, imiquimod induces local production of cytokines, such as interferon (IFN)-alpha. | |||||||||||||||
| |||||||||||||||
|
At 24 hr, a massive neutrophil recruitment and an induced expression of a wide spectrum of murine cytokine mRNA (i.e., interleukin [IL]-1 beta, IL-4, IL-6, IL-10, IL-12, tumor necrosis factor [TNF]-alpha and interferon [IFN]-gamma) occurred in the huPBL-SCID mouse peritoneal cavity. | |||||||||||||||
| |||||||||||||||
|
We detected a significant anesthesia-associated increase of interferon (IFN)-gamma, IFN-alpha, tumor necrosis factor-alpha, and soluble interleukin-2 receptor (sIL-2R) synthesis after stimulation with different mitogens while interleukin (IL)-1 beta and IL-6 protein did not change significantly. | |||||||||||||||
| |||||||||||||||
|
Recently, it has been shown that the complex of the four glycoproteins gB, gD, gH and gL, which are essential for viral attachment/entry (Fig. 3), expressed on the surface of Cos7 cells mediates monocyte-derived DC recognition via a nucleic acid-independent and TLR-independent pathway, leading to the up-regulation of CD40, CD83, CD86 and HLA-DR and to the production of IFN-? | |||||||||||||||
| |||||||||||||||
|
The production of pro-inflammatory, cytotoxic cytokines interferon-y (IFN-y), tumor necrosis factor-alpha, (TNF-alpha), interleukin-2 (IL-2) is reduced. | |||||||||||||||
| |||||||||||||||
|
We recently showed in CP local production of interferon (IFN)gamma, transforming growth factor (TGF)beta and death receptor ligand TRAIL (tumor necrosis factor-related apoptosis-inducing ligand), along with functional death receptor neoexpression and apoptosis in exocrine but not in endocrine cells. | |||||||||||||||
| |||||||||||||||
|
We detected a significant anesthesia-associated increase of interferon (IFN)-gamma, IFN-alpha, tumor necrosis factor-alpha, and soluble interleukin-2 receptor (sIL-2R) synthesis after stimulation with different mitogens while interleukin (IL)-1 beta and IL-6 protein did not change significantly. | |||||||||||||||
| |||||||||||||||
|
Peripheral blood mononuclear leukocytes were examined for IFN production induced by the IFN-alpha inducers Sendai virus and Escherichia coli and by the IFN-gamma inducers Concanavalin A and Lens culinaris lectin. | |||||||||||||||
| |||||||||||||||
|
Meclomen at nontoxic levels (10(-5) to 10(-8) mol/l) caused a 2-6 fold increase in interferon (IFN) production in lymphocytes induced by Sendai virus. | |||||||||||||||
| |||||||||||||||
|
Meclomen at nontoxic levels (10(-5) to 10(-8) mol/l) caused a 2-6 fold increase in interferon (IFN) production in lymphocytes induced by Sendai virus. | |||||||||||||||
| |||||||||||||||
|
Recent phase III data from the AVOREN trial have demonstrated that first-line bevacizumab plus IFN produces clinically important and statistically significant improvements in PFS and tumor response compared with IFN alone, irrespective of patient subgroups. | |||||||||||||||
| |||||||||||||||
|
Both AVOREN and CALGB 90206 show that bevacizumab plus IFN produces significant clinical benefit as first-line therapy for patients with metastatic RCC. | |||||||||||||||
| |||||||||||||||
|
[A case of hypothyroidism induced by interferon therapy for renal cell carcinoma]. | |||||||||||||||
| |||||||||||||||
|
We have investigated the in vitro effects of the neurohormone beta-endorphin (b-end) on natural killer (NK) activity and interferon (IFN) production mediated by large granular lymphocytes (LGL). | |||||||||||||||
| |||||||||||||||
|
General Comments
This test has worked.